SCHEMBL23876387

SCHEMBL23876387

CC1(C)c2ccccc2N2c3ccccc3Nc3cccc1c32

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KMT2A Q03164 6/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
PDK2 Q15119 1/20 0.38
PDK4 Q16654 1/20 0.38
LMNA P02545 3/20 0.35
HTT P42858 2/20 0.35
HSD17B10 Q99714 1/20 0.35
MAPT P10636 6/20 0.33
MEN1 O00255 5/20 0.33
KDM4E B2RXH2 2/20 0.33
AKT1 P31749 2/20 0.33
MAPK1 P28482 1/20 0.33
USP2 O75604 2/20 0.33
PGR P06401 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
HTR5A P47898 1/20 0.32
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12333544 0.85 KMT2A (0.43) GAAKMT2ACYP1A2CYP2D6LMNA
SCHEMBL15434752 0.83 KMT2A (0.42) GAASMN1; SMN2KMT2ACYP1A2CYP2D6
SCHEMBL17951856 0.81 GAA (0.50) GAASMN1; SMN2KMT2ACYP1A2LMNA
SCHEMBL15434753 0.80 KMT2A (0.42) GAAKMT2ACYP1A2CYP2D6LMNA
SCHEMBL12281541 0.79 KMT2A (0.39) GAAKMT2ACYP1A2CYP2D6LMNA
SCHEMBL24894036 0.77 LMNA (0.41) GAASMN1; SMN2LMNAHSD17B10KDM4E
SCHEMBL24894040 0.77 AKT1 (0.38) GAASMN1; SMN2KMT2ALMNAHSD17B10
SCHEMBL2453063 0.76 KMT2A (0.37) SMN1; SMN2KMT2ACYP1A2CYP2D6LMNA
SCHEMBL20152308 0.76 HTT (0.38) GAASMN1; SMN2KMT2ACYP1A2CYP2D6
SCHEMBL18639315 0.76 MGLL (0.42) GAASMN1; SMN2KMT2ACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337537-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES UDC IRELAND LIMITED (IE) 2023-10-19 US disclosed
WO-2023284486-A1 TETRADENTATE CYCLOMETAL PLATINUM(II) AND PALLADIUM(II) COMPLEX LUMINESCENT MATERIAL CONTAINING QUINOLINE STRUCTURAL UNIT AND APPLICATION THEREOF 浙江工业大学 2023-01-19 WO disclosed
WO-2021191058-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337537-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, PIEZO1, GPX1 GAA 2508/4885SMN1; SMN2 3093/4885KMT2A 2821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.